COVID-19大流行期间癌症患者管理:ESMO多学科专家共识
欧洲肿瘤内科学会牵头组建国际联盟,由62名全球专家和1名患者代表以虚拟共识会议形式,围绕从诊断到手术的10个工作包讨论并投票,最终形成28条共识声明,用于应对COVID-19大流行期间癌症诊疗中的临床与技术不确定性。
要点
- ESMO组织62名全球专家和1名患者代表形成28条共识声明。
- 共识覆盖从诊断到治疗规划及手术的临床问题。
- 共识旨在应对COVID-19大流行期间癌症管理的不确定性。
核心结论
- 专家组就28条共识声明达成一致,可用于应对COVID-19大流行期间从诊断到治疗规划及治疗的多个临床与技术不确定领域。
研究设计与样本
- 欧洲肿瘤内科学会牵头建立国际联盟,审查和讨论相关临床证据以制定专家共识声明。
- 指导委员会准备10个工作包,涵盖从诊断到手术的重要临床问题。
- 由62名全球专家和1名患者代表参加虚拟共识会议,对声明进行讨论、修改和投票;未达成共识时修订声明直至达成共识。
主要发现
- 专家组最终就28条共识声明达成一致。
临床怎么用
- 共识声明可用于COVID-19大流行期间癌症患者从诊断到治疗规划及治疗的管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
引用
- Curigliano G, Banerjee S, Cervantes A, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol. 2020. PMID: 32745693. doi:10.1016/j.annonc.2020.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。